St Jude’s full FAME II results validate benefits of FFR-guided PCI but will it be a significant driver?
This article was originally published in Clinica
Executive Summary
The latest positive results from St Jude Medical's FAME II trial of its fractional flow reserve (FFR) guidewires may help validate the clinical benefits of the technology, but analysts from JMP Securities seem less than impressed.